Science Explorer Interactive view Map
Company · Moscow · Russia

R-Pharm (Russia)

r-pharm.com/enROR OpenAlex
Research works
43
▲ 60% vs 2013–17
Citations
293
6.8 per fractional work
Top-10% rate
12.0%
record average 16.5%
Open access
74%
world 28%

Not ranked overall: R-Pharm (Russia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.33× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 8.28× its world share, 2 worksImmunology and Micro…Neuroscience: 1.56× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.96× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.21× its world share, 1 worksChemistryComputer Science: 0.20× its world share, 0 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.57× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.54× its world share, 0 worksMaterials ScienceMathematics: 0.81× its world share, 0 worksMathematicsHealth Professions: 0.60× its world share, 0 worksHealth ProfessionsMedicine: 2.86× its world share, 10 worksMedicineBusiness, Management and Accounting: 0.29× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.16× its world share, 0 worksEconomics, Econometr…Psychology: 0.10× its world share, 0 worksPsychologySocial Sciences: 0.07× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.0×. Every wedge is a field page.

Which keywords describe research at R-Pharm (Russia)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Immune Response, Cancer Therapy, Monoclonal Antibodies, Cytokines, Autoantibodies, Pandemic and ACE2 Receptor.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation6▲ 5.5×14 topics
  2. Immune Response4▲ 15×8 topics
  3. Cancer Therapy4▲ 13×10 topics
  4. Monoclonal Antibodies3▲ 52×3 topics
  5. Autoantibodies3▲ 27×4 topics
  6. Cytokines3▲ 24×6 topics
  7. Cancer2▲ 3.9×6 topics
  8. ACE2 Receptor2▲ 46×2 topics
  9. Pandemic2▲ 12×3 topics
  10. SARS-CoV-22▲ 36×2 topics
  11. Biopharmaceuticals2▲ 69×3 topics
  12. Glycosylation2▲ 21×3 topics
  13. Clinical Outcomes2▲ 22×2 topics
  14. Immunogenicity2▲ 84×2 topics
  15. Regulation2▲ 7.0×2 topics
  16. Tumor Microenvironment2▲ 12×3 topics
  17. Bioanalytical Methods2▲ 270×1 topic
  18. Biosimilars2▲ 270×1 topic
  19. Cell Proliferation2▲ 42×3 topics
  20. Adaptation2▲ 12×2 topics
  21. Biological Therapy2▲ 66×1 topic
  22. Cardiovascular Risk2▲ 11×2 topics
  23. Immunity2▲ 11×2 topics
  24. Rheumatoid Arthritis2▲ 36×1 topic
  25. Therapeutic Antibodies2▲ 27×2 topics
  26. Antibody Engineering1▲ 32×1 topic
  27. Breast Cancer1▲ 11×6 topics
  28. Fc Receptors1▲ 32×1 topic
  29. Immune System1▲ 10×5 topics
  30. PET Imaging1▲ 14×4 topics
  31. Coronavirus1▲ 24×1 topic
  32. Innate Immunity1▲ 8.0×5 topics
  33. Melanin1▲ 102×1 topic
  34. Oncogenic Mutations1▲ 62×2 topics
  35. Pigmentation1▲ 102×1 topic
  36. Stem Cells1▲ 9.1×3 topics
  37. Toll-like Receptors1▲ 16×2 topics
  38. Vaccine1▲ 7.1×1 topic
  39. IL-61▲ 76×1 topic
  40. Thrombosis1▲ 12×2 topics

Which research topics does R-Pharm (Russia) publish most on?

By volume in 2022–2025: Rheumatoid Arthritis Research and Therapies, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies and Biosimilars and Bioanalytical Methods.

Rheumatoid Arthritis Res…1Rheumatoid Arthritis Research and Therapies: 1 fractional worksSARS-CoV-2 and COVID-19 …1SARS-CoV-2 and COVID-19 Research: 1 fractional worksCOVID-19 Clinical Resear…1COVID-19 Clinical Research Studies: 1 fractional worksBiosimilars and Bioanaly…1Biosimilars and Bioanalytical Methods: 1 fractional worksSystemic Lupus Erythematosus Research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksSpondyloarthritis Studies and Treatments: 0 fractional worksLong-Term Effects of COVID-19: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional works
RheumatologyInfectious DiseasesImmunologyRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  3. 3 COVID-19 Clinical Research Studies Infectious Diseases 1 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 1 works
  5. 5 Systemic Lupus Erythematosus Research Rheumatology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 0 works
  8. 8 Spondyloarthritis Studies and Treatments Rheumatology 0 works
  9. 9 Long-Term Effects of COVID-19 Neurology 0 works
  10. 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.7%not open26.3%

World: 28% of research is openly available.

with international co-authors37.8%domestic only62.2%

World: 19% is written across borders.

How has R-Pharm (Russia)'s research output changed?

Output in 2018–2022 was 60% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Moscow

All research institutions in Moscow

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.